Modulating cholesterol 25-hydroxylase: a strategy to accelerate haematoma clearance after intracerebral haemorrhage to improve outcome

MRC · United Kingdom government procurement

This opportunity is now closed. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

Stroke is a life-threatening condition in which there is a disruption of blood supply to the brain. Haemorrhagic stroke is the deadliest type of stroke leading to a 50% chance of death, and those who survive are usually left with life-changing impairments that affect everyday living. The longer-term effects of stroke include difficulties with movement and balance, and problems with communication, remembering things, concentration, vision and swallowing as well as extreme fatigue. Currently there are no effective treatment options for haemorrhagic stroke so there is an urgent need to find new therapies to improve patient survival and quality of life. One type of haemorrhagic stroke ('intracerebral haemorrhage') occurs when a blood vessel suddenly ruptures and begins bleeding into the brain. Blood then accumulates inside the brain, leading to a rise in pressure that causes brain cells to die. Blood that is now in the brain contains various cells (including red blood cells) that start to release 'toxic factors' that can cause further damage to brain cells. It is important therefore, to try and get rid of the blood as quickly as possible, to reduce the chances of it causing any harm. Our tissues/organs contain a group of cells called 'phagocytes' whose job is to eat any harmful cells and smaller particles to try to protect our bodies from any of their harmful effects. In haemorrhagic stroke, these 'phagocytes' try to eat up the red blood cells and toxic factors. However, this job can take time and trying to find a way to help the phagocytes get rid of the blood quicker and more efficiently would help to prevent further damage to the brain. We have discovered that the amount of a protein called 'cholesterol 25-hydroxylase' (Ch25h) goes up in the phagocytes after haemorrhage, and we believe that this protein might help the phagocytes to work better to clear away the blood. In this application we will bring together a unique team of scientists who will use animal models...

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryConsulting
PublishedSeptember 30, 2023
Procurement stageActive solicitation
ClosedClosing date not published
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Browse Similar Open Opportunities in United Kingdom

Cwm Taf Water Supply Strategy Procurement Scheme - Direct Procurement for Customers (DPC)
Strategy Consulting Services
Digital Assessment and feedback framework
Flexible Framework for Adoption Support - Therapeutic and Specialist Assessment Services
Mechanical & Electrical (M&E) Engineering and Design Advisory Services Framework
PROVISION OF LARGE GOODS VEHICLE (LGV) TRAINING AND ASSESSMENT 2026- 2030 (3 LOTS)
Estate Agency Services for Herefordshire Council's Commercial Estate
Strategic Research and Advisory Support of IT and Cyber

See every United Kingdom Consulting opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Consulting intelligence report in your inbox

A personalized report on United Kingdom Consulting opportunities, emailed in 5-10 minutes. One per month, no account needed.